Biomedicines (Apr 2022)

PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis

  • Ehsan Sarafraz-Yazdi,
  • Stephen Mumin,
  • Diana Cheung,
  • Daniel Fridman,
  • Brian Lin,
  • Lawrence Wong,
  • Ramon Rosal,
  • Rebecca Rudolph,
  • Matthew Frenkel,
  • Anusha Thadi,
  • William F. Morano,
  • Wilbur B. Bowne,
  • Matthew R. Pincus,
  • Josef Michl

DOI
https://doi.org/10.3390/biomedicines10050945
Journal volume & issue
Vol. 10, no. 5
p. 945

Abstract

Read online

PNC-27, a 32-residue peptide that contains an HDM-2 binding domain and a cell-penetrating peptide (CPP) leader sequence kills cancer, but not normal, cells by binding to HDM-2 associated with the plasma membrane and induces the formation of pores causing tumor cell lysis and necrosis. Conformational energy calculations on the structure of PNC-27 bound to HDM-2 suggest that 1:1 complexes form between PNC-27 and HDM-2 with the leader sequence pointing away from the complex. Immuno-scanning electron microscopy was carried out with cancer cells treated with PNC-27 and decorated with an anti-PNC-27 antibody coupled to 6 nm gold particles and an anti-HDM-2 antibody linked to 15 nm gold particles. We found multiple 6 nm- and 15 nm-labeled gold particles in approximately 1:1 ratios in layered ring-shaped structures in the pores near the cell surface suggesting that these complexes are important to the pore structure. No pores formed in the control, PNC-27-treated untransformed fibroblasts. Based on the theoretical and immuno-EM studies, we propose that the pores are lined by PNC-27 bound to HDM-2 at the membrane surface with the PNC-27 leader sequence lining the pores or by PNC-27 bound to HDM-2.

Keywords